Elwood & Goetz Wealth Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
927
-9
-1% -$9.2K 0.16% 47
2026
Q1
$861K Buy
936
+499
+114% +$506K 0.15% 48
2025
Q4
$470K Buy
437
+49
+13% +$46.9K 0.08% 70
2025
Q3
$296K Buy
+388
New +$289K 0.06% 97
2025
Q1
Sell
-544
Closed -$420K 102
2024
Q4
$420K Buy
544
+10
+2% +$8.28K 0.1% 59
2024
Q3
$473K Hold
534
0.12% 57
2024
Q2
$483K Hold
534
0.14% 44
2024
Q1
$415K Hold
534
0.1% 56
2023
Q4
$311K Buy
534
+36
+7% +$21K 0.07% 65
2023
Q3
$267K Buy
+498
New +$257K 0.06% 64

Other funds holding LLY

Elwood & Goetz Wealth Advisory Group's LLY Position: Q2 2026 in Review

Elwood & Goetz Wealth Advisory Group reduced its Eli Lilly (LLY) stake by 0.96% in Q2 2026, selling an estimated $9.2K and leaving 927 shares worth $1.11M. The position accounts for 0.16% of the portfolio, ranked #47.

Elwood & Goetz Wealth Advisory Group first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elwood & Goetz Wealth Advisory Group held 927 shares of Eli Lilly worth $1.11M as of Q2 2026.
  • Elwood & Goetz Wealth Advisory Group sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.16% of Elwood & Goetz Wealth Advisory Group's portfolio in Q2 2026, its #47 holding.
  • Elwood & Goetz Wealth Advisory Group first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elwood & Goetz Wealth Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.